U.S. Supreme Court
Jun. 13, 2012
California securities case could affect other class actions
The U.S. Supreme Court agreed to hear a Southern California pharmaceutical company's challenge a judgment allowing investors to band together and collectively sue the company for allegedly manipulating its stock price.
Daily Journal Staff Writer
WASHINGTON - The U.S. Supreme Court agreed Monday to hear a Southern California biotechnology company's challenge to a judgment allowing investors to band together and collectively sue the company for allegedly manipulating its stock price.
Despite Amgen Inc.'s arguments to the contrary, the 9th U.S. Circuit Court of Appeals held that the investors don't have to show they took the compan...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In